Paper · 42947239
Phenotype rescue through the restoration of full-length dystrophin using CRISPR/Cas9 genome editing in Duchenne muscular dystrophy patient-derived iPSCs carrying the deletion of two exons.
Rovina D and 14 others. Genome Med, 2026.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Phenotype rescue through the restoration of full-length dystrophin using CRISPR/Cas9 genome editing in Duchenne muscular dystrophy patient-derived iPSCs carrying the deletion of two exons. Papers, record 42947239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42947239
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Phenotype rescue through the restoration of full-length dystrophin using CRISPR/Cas9 genome editing in Duchenne muscular dystrophy patient-derived iPSCs carrying the deletion of two exons.
- Journal
- Genome Med
- Year
- 2026
- Publication types
- Journal Article
- Revised in PubMed
- 2026-10-30
Source PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Induced Pluripotent Stem Cells | Major topic |
| Dystrophin | Major topic |
| Muscular Dystrophy, Duchenne | Major topic |
| CRISPR-Cas Systems | Major topic |
| Exons | Major topic |
| Gene Editing | Major topic |
| Sequence Deletion | Major topic |
| Humans | |
| Phenotype | |
| Myocytes, Cardiac | |
| Fibroblasts | |
| Cell Differentiation |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GR-2021-12375403 | Ministero della Salute | PubMed | ||
| GR-2021-12375403 | Ministero della Salute | PubMed | ||
| GR-2021-12375403 | Ministero della Salute | PubMed | ||
| 2764167 | Ministero della Salute | PubMed | ||
| 2764167 | Ministero della Salute | PubMed | ||
| 20223L2C9N | Ministero dell'Università e della Ricerca | PubMed | ||
| GUP19012 | Fondazione Telethon | PubMed | ||
| GUP19012 | Fondazione Telethon | PubMed | ||
| JTC2018-046 | European Commission ERA-NET on Cardiovascular Diseases | PubMed |
Source PubMed
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32,977,524 | "Betwixt Mine Eye and Heart a League Is Took": The Progress of Induced Pluripotent Stem-Cell-Based Models of Dystrophin-Associated Cardiomyopathy. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32977524 | PubMed |
| 2 | 39,056,750 | Cardiomyopathy in Duchenne Muscular Dystrophy and the Potential for Mitochondrial Therapeutics to Improve Treatment Response. | Cells | 2024 | https://conductscience.org/library/papers/39056750 | PubMed |
| 3 | 27,141,961 | Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. | Nucleic Acids Res | 2016 | https://conductscience.org/library/papers/27141961 | PubMed |
| 4 | 26,676,145 | Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy. | Physiol Rev | 2016 | https://conductscience.org/library/papers/26676145 | PubMed |
| 5 | 23,287,722 | RNA-guided human genome engineering via Cas9. | Science | 2013 | https://conductscience.org/library/papers/23287722 | PubMed |
| 6 | 18,406,573 | Early regional myocardial dysfunction in young patients with Duchenne muscular dystrophy. | J Am Soc Echocardiogr | 2008 | https://conductscience.org/library/papers/18406573 | PubMed |
| 7 | 33,772,245 | Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells. | Nat Protoc | 2021 | https://conductscience.org/library/papers/33772245 | PubMed |
| 8 | 32,656,189 | DMD Pluripotent Stem Cell Derived Cardiac Cells Recapitulate in vitro Human Cardiac Pathophysiology. | Front Bioeng Biotechnol | 2020 | https://conductscience.org/library/papers/32656189 | PubMed |
| 9 | 27,380,939 | Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. | Genome Biol | 2016 | https://conductscience.org/library/papers/27380939 | PubMed |
| 10 | 1,913,804 | Membrane organization of the dystrophin-glycoprotein complex. | Cell | 1991 | https://conductscience.org/library/papers/1913804 | PubMed |
1 to 10 of 93
See all 93 referencesCited by1
The papers in our copy of PubMed whose reference list names this one, newest first.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42,947,239 | Phenotype rescue through the restoration of full-length dystrophin using CRISPR/Cas9 genome editing in Duchenne muscular dystrophy patient-derived iPSCs carrying the deletion of two exons. | Genome Med | 2026 | https://conductscience.org/library/papers/42947239 |
Source PubMed
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42947239
GET https://conductscience.org/api/papers/v1/42947239/references?page=2